Clinical Trial Update: Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial compared praziquantel to artesunate plus sulfamethoxypyrazine/pyrimethamine for Schistosomiasis caused by Schistosoma haematobium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosomiasis

Drugs mentioned

• Artesunate (artesunate)
• Praziquantel (Praziquantel)
• Sulfamethoxypyrazine/Pyrimethamine (sulfamethoxypyrazine/pyrimethamine)

Snippet

Sponsor: Dafra Pharma | Conditions: Schistosoma Haematobium | Phase 2, Phase 3 | Status: COMPLETED